4Report of WHO/IFSC. task force on the definition and classification of cardio my pathies[J]. Br Heart J, 1980, 44:672.
5Colucci WS. Cardiovascular effects of milrinone[J ]. Am Heart J,1991,121 : 1945.
6Packer M. The development of positive inotropicm agents for chronic heart failure: How have we gone astray[J]? J AM Coll Cardiol, 1993, 22(SupplA) : 119A.
5Mauricio E R, Fabi6n P A, Luz-Patricia R S, et al. In- hibition of digestive enzyme activities by pectic polysac- charides in model solutions [ J]. Bioactive Carbohydrates and Dietary Fibre, 2014,4( 1 ) :27-38.
6Zeng Y F, Lee J, Si Y X, et al. Inhibitory effect of Zn2 + on c~-glucosidase: Inhibition kinetics and molecular dy- namics simulation [ J ]. Process Bioehem, 2012,47 ( 12 ) : 2510-2517.
7Cai S, Wang O, Wang M, et al. In vitro inhibitory effect on pancreatic lipase activity of subfractions from ethanol extracts of fermented Oats ( Avena sativa L. ) and syner- gistic effect of three phenolic acids [ J ]. J Agrie Food Chem, 2012,60 ( 29 ) : 7245 -7251.
8Yan J, Zhang G, Pan J, et al. cL-Glucosidase inhibition by luteolin: kinetics, interaction and molecular docking [J]. Int J Biol Macromol, 2014,64:213-223.
9Brindis F, Rodriguez R, Bye R, et al. (z)-3-butylide- nephthalide from ligusticum porteri, an alpha-glucosidase inhibitor[J]. J Nat Prod, 2011,74(3) :314-320.
10Hu Y H, Liu X, Jia Y L, et al. Inhibitory kinetics of chlorocinnamic acids on mushroom tyrosinase~ J]. J BiosciBioeng, 2014,117(2) :142-146.
